Literature DB >> 1151729

Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.

R W Fuller, K W Perry, B B Molloy.   

Abstract

3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140), when injected into rats at i.p. doses of 1 to 10 mg/kg, prevented the lowering of brain serotonin by 4-chloroamphetamine. The duration of 110140 action was very long, significant antagonism of 4-chloroamphetamine action being apparent still at 48 hours after a single dose of 10 mg/kg of 110140. The N,N-dimethyl tertiary amine derivative was as effective as 110140 itself in antagonizing serotonin depletion by 4-chloroamphetamine, but other structurally related compounds has less activity or were inactive. Likewise, six tricyclic antidepressant drugs injected at 10 mg/kg i.p. did not antagonize the action of 4-chloroamphetamine. When injected into rats whose brain serotonin levels had already been depleted by 3-hour pretreatment with 4-chloroamphetamine, 110140 terminated the action of 4-chloroamphetamine and permitted serotonin levels to return to normal. Lilly 110140 did not antagonize the depletion of brain serotonin or norepinephrine by reserpine, which implies that reserpine does not require the membrane pump for entry into the neuron. The depletion of brain serotonin, but not norepinephrine, by alpha-ethyl-3-hydroxy-4-methylphenethylamine (H75/12) was blocked by 110140. In contrast to chlorimipramine, 110140 did not antagonize the depletion of norepinephrine levels in heart and spleen by 6-hydroxydopamine. The data suggest that 110140 is a specific drug for inhibiting uptake into serotoninergic neurons in the brain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151729

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters.

Authors:  B Gao; W C Duncan; T A Wehr
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.

Authors:  D M Kuhn; W A Wolf; M B Youdim
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

3.  Astrocytes as a primary locus for the conversion MPTP into MPP+.

Authors:  W J Brooks; M F Jarvis; G C Wagner
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats.

Authors:  E Mogilnicka
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

5.  Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.

Authors:  J B Lassen; J Lund; I Søndergaard
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.

Authors:  V Sanchez; J Camarero; B Esteban; M J Peter; A R Green; M I Colado
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.

Authors:  L F Tseng
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

8.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

Authors:  B V Clineschmidt; J C McGuffin; A B Pflueger; J A Totaro
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

10.  Intracranial reward after Lilly 110140 (fluoxetine HCl): evidence for an inhibitory role for serotonin.

Authors:  R J Katz; B J Carroll
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.